日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma with 2-4 Prior Lines of Therapy: Updated Matching-Adjusted Indirect Comparison

在接受过三类药物治疗且既往接受过 2-4 线治疗的复发/难治性多发性骨髓瘤患者中,西他卡巴基因 Autoleucel 与艾达卡巴基因 Vicleucel 的疗效比较:更新的匹配调整间接比较

Lopez-Muñoz, Nieves; Bar, Noffar; Diels, Joris; van Sanden, Suzy; Mendes, João; Lee, Seina; Hernando, Teresa; Lendvai, Nikoletta; Patel, Nitin; Ishida, Tadao; Er, Jeremy; Harrison, Simon J

Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial

在参与 CARTITUDE-4 试验的多发性骨髓瘤患者中验证多发性骨髓瘤症状和影响问卷 (MySIm-Q)

Mina, Roberto; Mylin, Anne K; Yokoyama, Hisayuki; Magen, Hila; Alsdorf, Winfried; Shune, Leyla; Isufi, Iris; Harrison, Simon J; Shah, Urvi A; De Champlain, André; Katz, Eva G; Gries, Katharine S; Schecter, Jordan M; Lendvai, Nikoletta; Slaughter, Ana; Lonardi, Carolina; Deraedt, William; Costa Filho, Octavio; Patel, Nitin; Florendo, Erika; Ho, Kai Fai; Karlin, Lionel; Weisel, Katja

Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma

在 CARTITUDE-1 研究中,接受 Ciltacabtagene Autoleucel 治疗的复发/难治性多发性骨髓瘤患者获得长期(≥5 年)缓解和生存。

Jagannath, Sundar; Martin, Thomas G; Lin, Yi; Cohen, Adam D; Raje, Noopur; Htut, Myo; Deol, Abhinav; Agha, Mounzer; Berdeja, Jesus G; Lesokhin, Alexander M; Liegel, Jessica J; Rossi, Adriana; Lieberman-Cribbin, Alex; Usmani, Saad Z; Dhakal, Binod; Parekh, Samir; Li, Hui; Wang, Feng; Montes de Oca, Rocio; Plaks, Vicki; Sun, Huabin; Banerjee, Arnob; Schecter, Jordan M; Lendvai, Nikoletta; Madduri, Deepu; Lengil, Tamar; Zhu, Jieqing; Koneru, Mythili; Akram, Muhammad; Patel, Nitin; Costa Filho, Octavio; Jakubowiak, Andrzej J; Voorhees, Peter M

Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4

CARTITUDE-1、-2 和 -4 研究中,接受 ciltacabtagene autoleucel 输注治疗复发/难治性多发性骨髓瘤患者的颅神经麻痹临床经验

Rodríguez-Otero, Paula; Sidana, Surbhi; Kouwenhoven, Mathilde; Schecter, Jordan M; Lendvai, Nikoletta; De Braganca, Kevin C; Slaughter, Ana; Lonardi, Carolina; Vlummens, Philip; Varsos, Helen; Corsale, Christina; Madduri, Deepu; Zhao, Hao; Li, Katherine; Lee, Erin; Marquez, Loreta; Zhao, Man; Yeh, Tzu-Min; Chen, Diana; Plaks, Vicki; Montes de Oca, Rocio; Florendo, Erika; Patel, Nitin; Akram, Muhammad; Koneru, Mythili; Santomasso, Bianca D; Gállego Perez-Larraya, Jaime; van de Donk, Niels Wcj

Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison

Ciltacabtagene Autoleucel 与标准治疗方案治疗既往接受过治疗的复发或难治性多发性骨髓瘤患者的疗效比较:一项匹配调整的间接比较研究

Puig, Noemi; Diels, Joris; van Sanden, Suzy; Mendes, João; Burnett, Heather; Cichewicz, Allie; Lee, Seina; Hernando, Teresa; Schecter, Jordan M; Lendvai, Nikoletta; Patel, Nitin; Sanchez-Pina, José María; Rocchi, Serena; Mina, Roberto; Corradini, Paolo; Cavo, Michele; Miguel, Jesús San; Shune, Leyla; Khan, Abdullah M; Sidana, Surbhi; Leleu, Xavier; Manier, Salomon; Lipe, Brea; Weisel, Katja; Martinez-Lopez, Joaquin

Survival Outcomes with Cilta-cel Versus Conventional Treatment Regimens for Patients with Lenalidomide-Refractory Multiple Myeloma Using Inverse Probability of Treatment Weighting

采用逆概率加权法比较西替利嗪(Cilta-cel)与传统治疗方案治疗来那度胺难治性多发性骨髓瘤患者的生存结果

Fonseca, Rafael; Diels, Joris; Ghilotti, Francesca; Mendes, João; Van Hoorenbeeck, Sandra; Lee, Seina; Schecter, Jordan M; Lendvai, Nikoletta; Patel, Nitin; Triguero, Ana; Alsdorf, Winfried; van de Donk, Niels W C J; Ursi, Margherita

Real-World Treatment Patterns and Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and 1-3 Prior Lines of Therapy: Optum Database

复发/难治性多发性骨髓瘤患者(既往接受过 1-3 线治疗)的真实世界治疗模式和结果:Optum 数据库

Dhakal, Binod; Einsele, Hermann; Schecter, Jordan M; Deraedt, William; Lendvai, Nikoletta; Slaughter, Ana; Lonardi, Carolina; Nair, Sandhya; Varghese, Nirosha Elsem; He, Jianming; Kharat, Akshay; Lee, Seina; Cost, Patricia; Potluri, Ravi; Koneru, Mythili; Patel, Nitin; Florendo, Erika; Rodriguez-Otero, Paula; Yong, Kwee

Comprehensive Analysis of the NHX Gene Family and Its Regulation Under Salt and Drought Stress in Quinoa (Chenopodium quinoa Willd.)

藜麦(Chenopodium quinoa Willd.)NHX基因家族及其在盐胁迫和干旱胁迫下的调控的综合分析

Santhoshi, Yalla; Anjana, Asha Bindhu; Zala, Harshvardhan; Bosamia, Tejas; Tiwari, Kapil; Prajapati, Ketan; Patel, Pranay; Soni, Nishit; Patel, Nitin; Solanki, Satyanarayan; Kadam, Ulhas Sopanrao

Rare Case of Early Mycotic Ascending Aortic Aneurysm Following Transcatheter Aortic Valve Replacement

经导管主动脉瓣置换术后早期真菌性升主动脉瘤罕见病例报告

Sambyal, Bharat S; Patel, Nitin; Panda, Prashant; Sharma, Yash Paul

Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): results from a randomised, open-label, phase 3 trial

在来那度胺难治性多发性骨髓瘤患者中,接受 ciltacabtagene autoleucel 或标准治疗的患者报告结局 (CARTITUDE-4):一项随机、开放标签、3 期试验的结果

Mina, Roberto; Mylin, Anne K; Yokoyama, Hisayuki; Magen, Hila; Alsdorf, Winfried; Minnema, Monique C; Shune, Leyla; Isufi, Iris; Harrison, Simon J; Shah, Urvi A; Schecter, Jordan M; Vogel, Martin; Lendvai, Nikoletta; Gries, Katharine S; Katz, Eva G; Slaughter, Ana; Lonardi, Carolina; Gilbert, Jane; Li, Quanlin; Deraedt, William; Filho, Octavio Costa; Patel, Nitin; Florendo, Erika; Karlin, Lionel; Weisel, Katja